Skip to main content

Retinal Dystrophies clinical trials at UCSF

2 research studies open to eligible people

Retinal Dystrophies damage the retina, which can cause vision loss or blindness. UCSF is looking for participants for two clinical trials. One study is for a type of gene mutation that causes retinitis pigmentosa, which will track how the disease changes over time. The other study is an international eye imaging study for people who experience vision loss caused by damaged cones in the eye.

Showing trials for
  • EyeConic: Qualification for Cone-Optogenetics

    open to all eligible people

    This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.

    San Francisco, California and other locations

  • Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

    open to eligible people ages 10 years and up

    The purpose of this study is to characterize the natural history through temporal systemic evaluation of subjects identified with PRPF31 mutation-associated retinal dystrophy, also called retinitis pigmentosa type 11, or RP11. Assessments will be completed to measure and evaluate structural and functional visual changes including those impacting patient quality of life associated with this inherited retinal condition and observing how these changes evolve over time.

    San Francisco, California and other locations

Our lead scientists for Retinal Dystrophies research studies include .

Last updated: